UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009611 |
|---|---|
| Receipt number | R000011222 |
| Scientific Title | Phase I Clinical Study of Combination Therapy with Eribulin and Capecitabine in Patients with Progressive Recurring Breast Cancer(JBCRG-18Cape) |
| Date of disclosure of the study information | 2012/12/26 |
| Last modified on | 2021/07/08 10:51:34 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/12/22 07:46:40 | ||
| 2 | Update | 2013/06/14 16:36:31 | Recruitment status |
|
| 3 | Update | 2013/12/24 10:10:17 | Email |
|
| 4 | Update | 2013/12/24 10:10:35 | Last follow-up date |
|
| 5 | Update | 2013/12/24 10:15:55 | Target sample size |
|
| 6 | Update | 2014/01/23 10:30:34 | Institutions |
|
| 7 | Update | 2014/07/25 13:52:13 | Address Address TEL Address Address TEL |
|
| 8 | Update | 2014/12/25 13:31:12 | Recruitment status |
|
| 9 | Update | 2015/07/22 10:15:20 | Recruitment status |
|
| 10 | Update | 2018/08/24 10:06:55 | UMIN ID1 |
|
| 11 | Update | 2021/07/02 10:00:29 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 12 | Update | 2021/07/08 10:51:34 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Homepage URL Name of person sending information Name of person sending information Name of primary person or sponsor Organization Organization Organization Address Address Tel |
